Avalyn raises $100M to advance inhaled versions of approved lung disease meds

22nd July 2025 Uncategorised 0

Avalyn Pharma has added on $100 million to accelerate novel inhaled versions of approved drugs for lung conditions.

More: Avalyn raises 0M to advance inhaled versions of approved lung disease meds
Source: fierce